NAT10 and colorectal cancer: Zhang et al. identified that NAT10 fosters malignant progression in colorectal cancer, closely associating with immune infiltration and immunotherapy outcomes [27], while Liu et al. found that NAT10-mediated ac4C modification is significantly linked with inflammation-associated immune cells, highlighting its critical role in immune regulation [28].